Target intelligence / Profile preview

microRNA 6819 (MIR6819)

Target
MIR6819
Molecular classification
MicroRNA, Non-coding RNA, Small RNA molecule
01

Overview

MicroRNA 6819 (MIR6819) is a human microRNA—a small, non-coding RNA molecule involved in post-transcriptional regulation of gene expression. It acts primarily by binding to complementary sequences in target messenger RNAs (mRNAs), resulting in repression of translation or mRNA degradation[2][3][4]. MicroRNAs like MIR6819 are implicated in diverse biological processes, including immune responses, cell differentiation, and apoptosis, although the specific roles and validated targets of MIR6819 remain largely uncharacterized[4]. Preliminary studies have associated the circulating form, hsa-miR-6819-3p, with abnormal immune responses and post-exertional malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, suggesting possible biomarker potential[4].

Other names
hsa-mir-6819hsa-miR-6819-3pmicroRNA mir-6819MIR6819
02

Biological functions

Post-transcriptional regulation of gene expression (by binding and repressing target mRNAs)Potential roles in abnormal immune responsePossibly involved in cell differentiation, apoptosis, or other regulatory processes typical of microRNAs
03

Disease associations

Suggested involvement in immune dysfunction and post-exertional malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)Potential, but as yet unconfirmed, links with other diseases due to broad miRNA regulatory networks
04

Biomarkers

Circulating miRNAs—including MIR6819-3p—have been proposed as biomarkers for disease states (e.g., ME/CFS, immune dysfunction)Specific biomarker role for MIR6819 is not established but is under investigative consideration.

Beyond the preview

Go deeper on microRNA 6819 (MIR6819).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 6819 (MIR6819).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call